ArticleTheranostics2015

Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.

Emmy Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.